# A Pilot Study of Pivanex in Patients With Malignant Melanoma

> **NCT00087477** · PHASE1,PHASE2 · TERMINATED · sponsor: **Titan Pharmaceuticals** · enrollment: 14 (—)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** Pivanex

## Key facts

- **NCT ID:** NCT00087477
- **Lead sponsor:** Titan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 14 (—)
- **Last updated:** 2005-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087477, "A Pilot Study of Pivanex in Patients With Malignant Melanoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00087477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*